Item Type | Name |
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Carcinoma
|
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Carcinoma, Bronchogenic
|
Concept
|
Carcinoma, Intraductal, Noninfiltrating
|
Concept
|
Carcinoma, Small Cell
|
Academic Article
|
Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
|
Academic Article
|
Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.
|
Academic Article
|
Diagnosis and significance of liver metastases in small cell carcinoma of the lung.
|
Academic Article
|
Identifying prognostic factors in binary outcome data: an application using liver function tests and age to predict liver metastases.
|
Academic Article
|
Treatment of non-small-cell lung cancer.
|
Academic Article
|
Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
|
Academic Article
|
Insulin-like growth factor expression in human cancer cell lines.
|
Academic Article
|
Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer.
|
Academic Article
|
Monoclonal antibody alpha IR-3 inhibits non-small cell lung cancer growth in vitro and in vivo.
|
Academic Article
|
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
|
Academic Article
|
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity.
|
Academic Article
|
Pre-operative and post-operative treatments in stage III NSCLC.
|
Academic Article
|
Monoclonal antibodies that distinguish non-small cell from small cell lung cancer.
|
Academic Article
|
Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FunLc6Cer).
|
Academic Article
|
Clinical issues in the management of early lung cancer.
|
Academic Article
|
High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.
|
Academic Article
|
Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
|
Academic Article
|
[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
|
Academic Article
|
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
|
Academic Article
|
Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability.
|
Academic Article
|
Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
|
Academic Article
|
Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.
|
Academic Article
|
Screening for lung cancer: in pursuit of pre-metastatic disease.
|
Academic Article
|
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.
|
Academic Article
|
A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
|
Academic Article
|
Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
|
Academic Article
|
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
|
Academic Article
|
Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
|
Academic Article
|
cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion.
|
Academic Article
|
Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer.
|
Academic Article
|
Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4.
|
Academic Article
|
Initiators and promoters of lung cancer.
|
Academic Article
|
Surgical considerations with lung cancer screening.
|
Academic Article
|
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
|
Academic Article
|
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
|
Academic Article
|
Shared decision making and screening: an ongoing dialogue informed by data.
|
Academic Article
|
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
|
Academic Article
|
Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth.
|
Academic Article
|
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?
|
Academic Article
|
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
|
Academic Article
|
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.
|
Academic Article
|
Autocrine growth factors in human small cell lung cancer.
|
Academic Article
|
Alpha-amidation of peptide hormones in lung cancer.
|
Academic Article
|
Peripheral airway cell differentiation in human lung cancer cell lines.
|
Academic Article
|
Clinical practice. Lung cancer screening.
|
Academic Article
|
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
|
Academic Article
|
Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets.
|
Academic Article
|
Anticancer antibodies for lung cancer.
|
Academic Article
|
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
|
Academic Article
|
Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers.
|
Academic Article
|
Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features.
|
Academic Article
|
Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection.
|
Academic Article
|
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
|
Academic Article
|
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
|
Academic Article
|
Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
|
Academic Article
|
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
|
Academic Article
|
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
|
Academic Article
|
In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung.
|
Academic Article
|
Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.
|
Academic Article
|
Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
|
Academic Article
|
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
|
Academic Article
|
Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
|
Academic Article
|
Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
|
Academic Article
|
Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.
|
Academic Article
|
Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.
|
Academic Article
|
Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.
|
Academic Article
|
Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.
|
Academic Article
|
The correct dose: pharmacologically guided end point for anti-growth factor therapy.
|
Academic Article
|
Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.
|
Academic Article
|
RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma.
|
Academic Article
|
Candidate biomarkers for application as intermediate end points of lung carcinogenesis.
|
Academic Article
|
Advancing patient-centric genomic medicine.
|
Academic Article
|
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
|
Academic Article
|
Improved antigen detection in ethanol-fixed cytologic specimens. A modified avidin-biotin-peroxidase complex (ABC) method.
|
Academic Article
|
A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line.
|
Academic Article
|
The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group.
|
Academic Article
|
Cross validation of cluster analysis using immunostained multi-tissue tumour block slides.
|
Academic Article
|
Randomized trial of neoadjuvant therapy for lung cancer: interim analysis.
|
Academic Article
|
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium.
|
Academic Article
|
Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?
|
Academic Article
|
hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.
|
Academic Article
|
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.
|
Academic Article
|
Lung cancer: current therapies and new targeted treatments.
|